Sexual Dysfunction

"I can't speak for the FDA, but I would hope and anticipate that the results of this trial may lead to a modification of the label and the warning," says A. Michael Lincoff, MD.

"The principal finding was non inferiority," says A. Michael Lincoff, MD.

A. Michael Lincoff, MD, shares the impetus for the TRAVERSE study.

“Our data show that low T is an independent risk factor for adverse peri-op outcomes after transurethral prostate surgery,” says Jasmine Lin, MD.

Clinical research has demonstrated a 10-minute onset interval for the topical gel formulation MED3000, compared to an interval of at least 30 minutes with PDE5 inhibitors, such as Cialis and Viagra.

"We believe that more thorough body weight control in childhood could serve as a preventive measure for preserving testicular function in adulthood," says Rosella Cannarella, MD, PhD.

“We need to continue to advocate for the patient,” says Arthur L. Burnett II, MD, MBA.

“There really is a significant lack in sexual medicine research of cost information, care information, [and] outcomes information,” says Martin S. Gross, MD.

“Patients are paying humongous amounts of money to get pills that are essentially very, very, very cheap,” says Faysal A. Yafi, MD, FRCSC.

“I would classify hidden burdens as things which we don't appreciate on the surface, or that aren't obvious that are associated with erectile dysfunction,” says John J. Mulcahy, MD, PhD.

“Collagenase [clostridium histolyticum (Xiaflex)] is a really important part of our treatment armamentarium,” says Matthew J. Ziegelmann, MD.

“[Collagenase clostridium histolyticum (Xiaflex)] is an incredibly important part of the treatment armamentarium for Peyronie's disease in the US,” says Matthew J. Ziegelmann, MD.

“I think the most notable finding is that we did see continued benefit from each injection series,” says Matthew J. Ziegelmann, MD.

“I am interested in looking at postpartum issues for sexual function,” says Rachel Pope, MD, MPH.

“For a lot of women with lichen sclerosis, they actually go for years without being diagnosed,” says Rachel Pope, MD, MPH.

“I would have to say the most exciting part of the whole conference was how many medical students and trainees were there,” says Rachel Pope, MD, MPH.

“I would just burn it into everyone's brain that pain with intercourse is also going to be associated with genitourinary syndrome of menopause,” says Rachel Pope, MD, MPH.

“There's a huge potential role for urologists out there for female sexual health,” says Rachel Pope, MD, MPH.

“There are just a lot of barriers, unfortunately, to speaking freely about women's sexual health,” says Rachel Pope, MD, MPH.

The spray is a liquid suspension of sildenafil citrate administered orally via a spray pump.

In this interview, Ira Sharlip, MD, explains the potential dangers these products pose and what urologists can do to help protect their patients.

“What we found is that the majority of these companies…offered our ‘secret shopper’ testosterone therapy,” says Joshua A. Halpern, MD, MS.

This clinical consensus statement on vaginal energy-based devices (EBDs) reflects an update by content experts from the American Urogynecologic Society’s EBD writing group.

“We're trying to see if combining shockwave therapy along with PRP will make an additive impact on the improvement in erectile function in men with erectile dysfunction,” says Ranjith Ramasamy, MD.

“I think a clinical trial like this that is funded by the NIH and taxpayer dollars will hopefully provide an unbiased answer of whether it works and who it works in,” says Ranjith Ramasamy, MD.

Treatment of azoospermia after exogenous testosterone use may require aggressive medical therapy, according to Kelli Gross, MD.

Joshua A. Broghammer, MD, discusses the development and use of intracavernosal injections for the treatment of patients with erectile dysfunction.

Joshua A. Broghammer, MD, discusses the use of penile implants in the field of urology, detailing both the semi-rigid and inflatable penile prostheses.

“Community urologists need to interact more intimately with academic urologists so all of us have a voice in this direct-to-consumer conversation," says 1 urologist.

Among the topics touched on in the discussion are lifestyle considerations, medical therapy, and surgical options.